Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Canopy Growth

SNDL Inc.

It might not seem like penny stocks and Twinkies go together. But with the latest surge in marijuana stocks, Hostess stock might not be the worst complement to the cannaboom in 2023.

3 Marijuana Penny Stocks To Watch After Hostess Stock News

NASDAQ | TSX: ACB EDMONTON, AB , Sept. 8, 2023 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $12.3 million (US$9.0 million) principal amount of its convertible senior notes ("Notes") in multiple transactions between August 16 and September 8, 2023 at a total cash cost of $12.3 million (~US$9.0 million), including accrued interest, satisfied by the issuance of an aggregate ~20.1 million common shares of Aurora.

Aurora Repurchases ~US$9.0 Million Principal Amount of Convertible Notes; Continues Progress Towards Positive Free Cash Flow with less than ~US$39 Million of Notes Outstanding

Curaleaf Holdings, Inc.

Momentum for passage of marijuana reform legislation keeps growing, and senators are confident the SAFE Banking Act will pass. A new study touts the benefits of medical marijuana for pain amelioration.

Why Canopy Growth, Aurora Cannabis, and Curaleaf Stocks All Popped Today

NASDAQ | TSX: ACB Proceeds from Strain for Heroes sales to support veteran organizations across Canada EDMONTON, AB, Sept. 7, 2023 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced the launch of Honour, a new cannabis cultivar designed for veterans, by veterans and the second offering from Aurora's Strain for Heroes portfolio.

Aurora Expands Strains for Heroes Offerings Designed for Veterans, by Veterans

Cronos Group

Easterly Government Properties

Harte Hanks

Philip Morris

Constellation Brands

Tilray Brands

Stocks that deal in cannabis are rising as the U.S. government moves toward re-classifying marijuana. The Department of Health and Human Services (HHS) has asked the Drug Enforcement Administration (DEA) to consider moving marijuana from Schedule I to Schedule III.

Why Are Cannabis Stocks Still Up Today?

NASDAQ | TSX: ACB  Full-Spectrum, Single-Source 3% CBD Oil will be First Product to Launch EDMONTON, AB , Sept. 6, 2023 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis and Canada's largest medical cannabis company, today announced an expansion of its hemp-derived CBD portfolio into Brazil.

Aurora Cannabis Partners with leading Brazilian company Herbarium to expand CBD Portfolio into Brazil

Innovative Industrial Properties

Chicago Atlantic Real Estate Finance

Curaleaf Holdings Inc. OTCMKTS: CURLF,  Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Human Services recommended that marijuana no longer be classified as a Schedule 1 drug.

Will This New Development Mean A Big Rally In Cannabis Stocks?

Cannabis stocks have come roaring back on recent news of major decriminalization progress at the federal level. The big question now for anyone who owns marijuana stocks or is considering the sector: Is there more upside left?

Cannabis stocks are still a buy despite recent double-digit gains

Green Thumb Industries Inc.

Last month, the Department of Health and Human Services suggested easing regulations on marijuana use. The Drug Enforcement Agency has final say on that -- but its boss, President Joe Biden, now says he supports medical marijuana legalization.

Why Marijuana Stocks Keep Growing Higher Tuesday

OrganiGram Holdings Inc.

Trulieve Cannabis Corp.

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.

Cannabis stock rally continues on marijuana rescheduling hopes

The cannabis industry is still evolving and has had its fair share of ups and downs. There has been an ongoing battle to establish better laws and regulations. Right now many legal states are facing concerns of high state taxes and other regulatory concerns. This has made it tough not just to invest but also to see sustainable market momentum. Still, there is a lot to look forward to as overall progress continues for the industry.

3 Marijuana Stocks To Buy In September?

If marijuana is downgraded to a Schedule III drug, it could be a huge boost to a struggling industry.

U.S. health officials want to loosen marijuana restrictions. Here's what it means

Cannabis stocks are up on Thursday as investors in the market react to news marijuana may be downgraded from a Schedule I drug. According to insiders, a member of the Department of Health and Human Services is seeking a drop in the drug from Schedule I to Schedule III.

Why Are Cannabis Stocks TLRY, ACB, CGC, CURLF Up Today?

AdvisorShares Pure US Cannabis ETF

Shares of marijuana companies climbed as much as 14% in morning trading on Thursday after the Department of Health and Human Services recommended its reclassification as a lower-risk substance following an 11-month review.

Pot firms gain as US move to ease curbs boosts sentiment

The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug, reviving hope among investors and marijuana producers for an industry that took off like a rocket five years ago before sinking like a rock less than two years later.

Will a Change to US Marijuana Policy Save Any of the Weed Companies?

Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.

Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drug

Roundhill Cannabis ETF

The Drug Enforcement Agency received an official recommendation to downgrade marijuana.  Currently, pot is classified as a Schedule I drug, on par with heroin.

Pot stocks jump as federal agency reportedly seeks to downgrade cannabis from the hard-drug category

With the chances of marijuana companies accessing the U.S. financial system higher than ever and cannabis stocks trading at lower valuations than ever before, now looks like an excellent time to seek out top-notch cannabis stocks to buy. Regarding access to the American financial system, Senate Majority Leader Chuck Schumer, a Democrat, appears to be working hard to enable the cannabis sector to obtain this much-needed change.

These Are the ONLY 3 Cannabis Stocks to Consider in August 2023

High Tide

Jazz Pharmaceuticals

I will attempt to assess and rank the relative growth potential of the separate competitors in the industry. The industry faces multiple catalysts and is trading near 52-week lows. The cannabis ETFs are full of cash burning companies, so I am forced to research my own basket of stocks.

Finding The Long-Term Winners In The Cannabis Sector, August 2023 Update

Despite the ongoing challenges, the cannabis industry has been responsive to innovation, growth, and transformation. The article lists three key players poised to capitalize on unique aspects of the cannabis market.

3 Cannabis Stocks to Snap Up Before They Skyrocket

NASDAQ | TSX: ACB EDMONTON, AB , Aug. 14, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held today, Monday, August 14, 2023 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 92,897,315, representing 26.23% of Aurora's issued and outstanding common shares as of the record date.

Aurora Cannabis Announces Results of 2023 Annual General Meeting

Marijuana stocks have had an interesting 2023, to say the least. Some feel that this year was one of growth and social acceptance of the plant. For instance, more states have legalized cannabis and this has led to an increase in all-around cannabis use. Although not everyone may not be comfortable with cannabis there has been a tremendous social shit.

3 Top Canadian Marijuana Stocks For Cannabis Investors

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.08 per share a year ago.

Aurora Cannabis Inc. (ACB) Reports Q4 Loss, Tops Revenue Estimates

Aurora Cannabis Inc. (NASDAQ:ACB ) Q2 2023 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants Ananth Krishnan - VP, Corporate Development and Strategy Miguel Martin - CEO Glen Ibbott - CFO Conference Call Participants Michael Lavery - Piper Sandler John Zamparo - CIBC Operator Greetings. And welcome to the Aurora Cannabis Inc. First Quarter 2024 Results Conference Call.

Aurora Cannabis Inc. (ACB) Q2 2023 Earnings Call Transcript

Achieves Quarterly Net Revenue 1 of $75.1 Million; Strong YoY Growth Across All Business Units; Global Medical Cannabis +14%, Consumer Cannabis +5% , Plant Propagation +12% Delivers Third Sequential Quarter of Positive Adjusted EBITDA 1 , Supported by Bevo's Record Quarterly Revenue Cash Used in Operating Activities Reduced by $15.5 Million YoY, Re-Affirms Target of Positive Free Cash Flow in Calendar Year 2024 NASDAQ | TSX: ACB EDMONTON, AB , Aug. 10, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced its financial and operational results for the first quarter of fiscal year 2024. As the fiscal year 2023 consisted of three quarters, the year-over-year comparison quarter for Q1 2024 ending June 30, 2023 is Q4 2022 ending June 30, 2022.

News for Aurora Cannabis Stock (ACB)